BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New York City. Ilan Sobel, CEO of BioHarvest Sciences, will conduct 1x1 meetings with...
2024-09-04 8:30 AM EDT
BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced its financial and operational results for the second quarter ended June 30, 2024. Second Quarter & Subsequent 2024 Operational Highlights All figures st
2024-08-29 9:22 AM EDT
BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA® Superfood Coffee and Decaf Coffee, a "functional" coffee product line integrating flagship nutraceutical product VINIA® Red Grape Superfood into a premium coffee in the popular Keurig compatible pod format, has surpassed USD $1.0...
2024-08-28 9:56 AM EDT
BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, August 29, 2024. On the call, CEO Ilan Sobel will discuss commercial progress and new product marketing initiatives, second quarter 2024 financial results, third quarter 2024 forecasts, and...
2024-08-23 8:30 AM EDT
BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) ("BioHarvest" or the "Company") has closed the first tranche of its private placement announced on June 21, 2024. The Company issued 603,904 share units at USD $7.17 per unit raising a total of USD $4,329,982.62 (approx. CAD $5,926,000). Each unit includes one common share, one-quarter of a USD $7.68 warrant expiring in 6 months, and one-quarter of a USD...
2024-06-28 2:52 PM EDT
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024. CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a...
2024-06-24 8:30 AM EDT
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), announced today that its board of directors have approved a private placement of up to 697,350 units at a price of USD $7.17 per unit (approx. CAD $9.82) for gross proceeds of up to USD $5,000,000 (approx. CAD $6,847,000). Each Unit includes one common share, one-quarter (1/4) of a USD $7.68 Warrant (approx. CAD $10.50), and one-quarter...
2024-06-21 8:30 AM EDT
BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the Sidoti Small-Cap Investor Conference, being held June 12-13, 2024. CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a...
2024-06-12 4:16 PM EDT
BioHarvest Sciences Announces Record $2 Million Monthly Sales
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 6, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that VINIA®, the first commercialized product created on the Botanical Synthesis platform, set a record for monthly sales orders in May 2024 of US$1.98M, representing a 101% increase as compared to May 2023. Sales growth in BioHarvest's Products...
2024-06-06 8:30 AM EDT
BioHarvest Sciences Reports First Quarter 2024 Financial Results
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter ended March 31, 2024. First Quarter & Subsequent 2024 Operational Highlights Revenue in the first quarter
2024-05-30 8:30 AM EDT
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, May 2nd to discuss recently announced milestone achievements, including full year 2023 financial results, and the recent acquisition of an expanded corporate campus. CEO Ilan Sobel...
2024-05-01 9:15 AM EDT
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technol
2024-04-30 8:00 AM EDT
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced the signing of two agreements: an equipment purchase agreement for 12 state of the art G
2024-04-16 8:00 AM EDT
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of experienced life sciences executive Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables, to drive broader expansion of the Company's recently launched Contract Development and Manufacturing...
2024-03-21 8:30 AM EDT
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it has been invited to participate in the Benzinga Virtual Healthcare Summit 2024 on March 20, 2024. Benzinga's Virtual Healthcare Summit is an immersive virtual event where the brightest minds in healthcare, influential...
2024-03-14 8:30 AM EDT
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of two senior hires in the areas of business development and science to spearhead key initiatives as part of the Company's recently launched CDMO Services Business Unit. "Our new CDMO Services division is such a...
2024-03-13 9:21 AM EDT
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on March 12-13, 2024. CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event,...
2024-03-07 8:30 AM EST
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update webinar on Wednesday, March 13th to discuss the Company's Contract Development and Manufacturing Organization ("CDMO") business unit. The new CDMO business unit allows pharmaceutical,...
2024-02-29 11:15 AM EST
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering the Botanical Synthesis process technology, has announced the official launch of its new Contract Development and Manufacturing Organization (CDMO) business unit. The Company is also announcing that this new unit has recently signed two contracts to develop complex molecules - for a...
2024-02-26 8:30 AM EST
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 20, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), is issuing this news release to expand on and clarify its news release issued February 15, 2024 the "Original Release" regarding engagement of MZ Group, at the request of CIRO. Additional Information to Original Release Under the terms of the Agreement with MZ Group dated February 13, 2024, the Company will pay monthly...
2024-02-20 2:16 PM EST